Help Avoid Interruptions in Opioid Use Disorder Treatment

You're on the front lines to help patients overcome obstacles to getting meds for opioid use disorder (Suboxone, etc) during COVID-19.

About 1 in 3 patients with opioid use disorder (OUD) report changes or disruptions in care during the pandemic...such as trouble getting treatment with buprenorphine/naloxone, methadone, or naltrexone.

This is a big deal...barriers to care, isolation, and stress can lead to relapse.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote